Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62

United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$51.07M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$29.62M

$8.42M on a plan · $4.41M straight out of an exercise

Sold at will

$16.79M

24 of 96 sales

Net

+$21.46M

+$34.29M against sales at will